- Newer treatments for advanced hepatocellular carcinoma
-
Song MJ, Bae SH
- KMID: 1792028
- Korean J Intern Med.
- 2014 Mar;29(2):149-155.
- doi: 10.3904/kjim.2014.29.2.149
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The only curative treatment modalities for HCC are surgery, percutaneous ablation, and liver transplantation. Unfortunately, the majority of patients... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
-
Seo MS, Kim JK, Shim JY
- KMID: 2163643
- Yonsei Med J.
- 2015 Sep;56(5):1449-1452.
- doi: 10.3349/ymj.2015.56.5.1449
We report a case of regression of multiple pulmonary metastases, which originated from hepatocellular carcinoma after treatment with intravenous administration of high-dose vitamin C. A 74-year-old woman presented to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm
-
Hwang S, Lee J, Lee JM, Hong SH, Lee MA, Chun HG, Chun HJ, Lee SH, Jung ES
- KMID: 2373312
- Korean J Gastroenterol.
- 2015 Jul;66(1):50-54.
- doi: 10.4166/kjg.2015.66.1.50
The occurrence of hepatocellular carcinoma (HCC) is closely associated with viral hepatitis or alcoholic hepatitis. Although active surveillance is ongoing in Korea, advanced or metastatic HCC is found at initial... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status of Molecular Targeted Therapies in Hepatocellular Carcinoma
-
Suh SJ, Yim HJ
- KMID: 1501636
- Korean J Gastroenterol.
- 2013 Mar;61(3):136-146.
- doi: 10.4166/kjg.2013.61.3.136
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death in Korea. Curative treatment is only possible when the disease is diagnosed at the early stage. The prognosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
-
Kim JO, Jun DW, Tae HJ, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC, Hahm JS
- KMID: 2155295
- Clin Mol Hepatol.
- 2015 Mar;21(1):85-88.
- doi: 10.3350/cmh.2015.21.1.85
Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation... -
- CITED
-
- Close
- SHARE
-
- Close
